IRAK1 and leukemia: Inhibition of IRAK4 and IRAK1, either with short hairpin RNA (shRNA) or with an IRAK1/4dual inhibitor, resulted in decreased expression of IL-17 and interferon-γ (IFN-γ), as well as reduced progression of T-ALL proliferation in a murine leukemia model.